Schneider lab
 |
Tanja Schneider studied biology in Bonn, Germany, specialized in microbiology and obtained her PhD in 2004. Following a postdoctoral training at the Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, she joined industry from 2011 until 2012. During that time she worked at the Peptide and Cell Discovery Department at Novozymes A/S, Denmark in the course of a Marie Curie Actions fellowship. Returning to Germany, she became a junior research group leader within the German Center for Infection Research (DZIF). In 2014 she completed her habilitation in Medical-Pharmaceutical Microbiology and was appointed Professor of Pharmaceutical Microbiology at the University of Bonn in 2015. |
Research The AG Schneider studies the bacterial cell envelope as a target for (new) antibiotics. Much of our current research focuses on the elucidation of molecular mechanisms of action and resistance of (new) antibiotics and the identification & characterization of novel antibacterial targets. Pivotal to these efforts is to understand the biology beyond a given target as well as its integration into the cellular network. |
|
Funding
- German Centre for Infection Research (DZIF), TTU Novel Antibiotics
- National Institute of health (NIH), “Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatment“
- InfectControl 2020
- DFG, FOR 854: "Post-Genomic Strategies for New Antibiotic Drugs and Targets"
- Maria-von-Linden Programme, University of Bonn
Team members
Tanja Schneider
Head of Department
Tanja Schneider studied biology in Bonn, Germany, specialized in microbiology and obtained her PhD in 2004. Following a postdoctoral training at the Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, she joined industry from 2011 until 2012. During that time she worked at the Peptide and Cell Discovery Department at Novozymes A/S, Denmark in the course of a Marie Curie Actions fellowship. Returning to Germany, she became a junior research group leader within the German Center for Infection Research (DZIF). In 2014 she completed her habilitation in Medical-Pharmaceutical Microbiology and was appointed Professor of Pharmaceutical Microbiology at the University of Bonn in 2015.
phone: +49(0)228 73 5688
Anna Müller
Postdoctoral Fellow
Anna Mueller studied molecular biomedicine, specialized in microbiology and received her Ph.D. from the University of Bonn in 2015. She is currently a postdoctoral researcher in the group of Prof. Dr. Tanja Schneider at the Institute of Pharmaceutical Microbiology (University of Bonn, Germany) studying the molecular mechanisms of action of novel antibiotic compounds, with particular emphasis on inhibitors that target cell wall biosynthesis.
room 101
phone: +49(0)228 73 4588
